|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.04 - 0.04|
|52 Week Range||0.03 - 0.30|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 31, 2017 - Apr 3, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
ADDISON, Texas, April 3, 2017 /PRNewswire/ -- ULURU Inc. (ULUR), a specialty medical technology company focused on the development of a portfolio of wound management and oral drug delivery products, today announced it has completed the second closing under the Note, Warrant and Preferred Stock Purchase Agreement with Velocitas Partners, LLC and its affiliates (collectively "Velocitas") under which the Company received $6,000,000 in gross proceeds in two closings (the "Financing").
ADDISON, Texas, Feb. 28, 2017 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), a specialty medical technology company focused on the development of a portfolio of wound management and oral drug delivery products, ...